Etoposide induces chromosomal abnormalities in mouse spermatocytes and stem cell spermatogonia

Human Reproduction

Volumn 21, Issue 4, 2006, Pages 888-895

  Marchetti, Francesco ^a   Pearson, Francesca S ^a   Bishop, Jack B ^b   Wyrobek, Andrew J ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Aneuploidy; Chemotherapy; FISH; Male germ cells; Structural aberrations

Indexed keywords

ETOPOSIDE;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CONTROLLED STUDY; DOSE RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; FREQUENCY ANALYSIS; GERM CELL; MALE; MEIOSIS; MOUSE; NONHUMAN; PACHYTENE; REPRODUCTIVE TOXICITY; SEMEN ANALYSIS; SPERMATOCYTE; SPERMATOGONIUM; STEM CELL; STRUCTURAL CHROMOSOME ABERRATION;

ANIMALIA;

EID: 33645287287     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei416     Document Type: Article

References (55)

1. Adler ID (1996) Comparison of the duration of spermatogenesis between male rodents and humans. Mutat Res 352,169-172.
2. American Cancer Society (2005) Cancer figures and facts. http://www.cancer.org
3. Anderson RD and Berger NA (1994) Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat Res 309,109-142.
4. Atria SM, Schmid TE, Badary OA, Hamada FM and Adler ID (2002) Molecular cyrogenetic analysis in mouse sperm of chemically induced aneuploidy: studies with topoisomerase II inhibitors. Mutat Res 520,1-13.
5. Baguley BC and Ferguson LR (1998) Mutagenic properties of topoisomerase-targeted drugs. Biochim Biophys Acta 1400,213-222.
6. Bishop JB, Marchetti F, Shelby MD, Generoso WM, Lowe X and Wyrobek AJ (1997) A novel pattern of male germ cell mutagenicity induced by etoposide in mice. Environ Mol Mutagen 29,31.
7. Boyle AL and Ward D (1992) Isolation and initial characterization of a large repeat sequence element specific to mouse chromosome 8. Genomics 12,517-525.
8. Broun ER, Nichols CR, Gize G, Cornetta K, Hromas RA, Schacht B and Einhorn LH (1997) Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 79,1605-1610.
9. Cimini D, Antoccia A, Tanzarella C and Degrassi F (1997) Topoisomerase II inhibition in mitosis produces numerical and structural chromosomal aberrations in human fibroblasts. Cytogenet Cell Genet 76,61-67.
10. Cobb J, Reddy RK, Park C and Handel MA (1997) Analysis of expression and function of topoisomerase I and II during meiosis in male mice. Mol Reprod Dev 46,489-498.
11. De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, Mieusset R and Bujan L (2001) Increased aneuploidy in spermatozoa from testicular tumor patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod 16,1204-1208.
12. DiNardo S, Voelkel K and Sternglanz R (1984) DNA topoisomerase II mutant of Saccharomices cerevisiae: Topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. PNAS 81,2616-2620.
13. Disteche CM, Carrano AV, Ashworth LK, Burkhart-Schultz K and Latt SA (1981) Flow sorting of the mouse Cattanach×chromosome, T(X;7)1 Ct in an active or inactive state. Cytogenet Cell Genet 29,189-197.
14. Downes CS, Mullinger AM and Johnson RT (1991) Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent from exit from meiosis. PNAS 88,8895-8899.
15. Einhorn LH (1997) Testicular cancer: An oncological success story. Clin Cancer Res 3,2630-2632.
16. Ferguson LR and Baguley BC (1994) Topoisomerase II enzymes and mutagenicity. Environ Mol Mutagen 24,245-261.
17. Ferguson LR and Baguley BC (1996) Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes. Mutat Res 355,91-101.
18. Frias S, Van Hummelen P, Meistrich ML, Lowe XR, Hagemeister FB, Shelby MD, Bishop JB and Wyrobek AJ (2003) NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21. Cancer Res 63,44-51.
19. Genesca A, Caballin MR, Mire, R, Benet J, Bonfill X and Egozcue J (1990) Human sperm chromosomes. Long-term effects of cancer treatment. Cancer Genet Cytogenet 46,251-260.
20. Hill FS, Marchetti F, Liechty M, Bishop J, Hozier J and Wyrobek AJ (2003) A new FISH assay to simultaneously detect structural and numerical chromosomal abnormalities in mouse sperm. Mol Reprod Dev 66,172-80.
21. Howell SJ and Shalet SM (2005) Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 34,12-17.
22. Kallio M and Lähdetie J (1993) Analysis of micronuclei induced in mouse early spermatids by mitomycin C, vinblastine sulfate or etoposide using fluorescence in situ hybridization. Mutagenesis 8,561-567.
23. Kallio M and Lähdetie J (1997) Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic division in vivo: Cell cycle arrest and induction of aneuploidy. Environ Mol Mutagen 29,16-27.
24. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58,351-375.
25. Lowe X, O'Hogan S, Moore Dn, Bishop J and Wyrobek A (1996) Aneuploid epididymal sperm detected in chromosomally normal and Robertsonian translocation-bearing mice using a new three-chromosome FISH method. Chromosoma 105,204-210.
26. Lowe X, de Stoppelaar JM, Bishop J, Cassel M, Hoebee B, Moore DI and Wyrobek AJ (1998) Epididymal sperm aneuploidies in three strains of rats detected by multicolor fluorescence in situ hybridization. Environ Mol Mutagen 31,125-132.
27. Mailhes JB, Marchetti F, Phillips GLJ and Barnhill DR (1994) Preferential pericentric lesions and aneuploidy induced in mouse oocytes by the topoisomerase II inhibitor etoposide. Teratogen Carcinogen Mutagen 14,39-51.
28. Mailhes JB, Marchetti F, Young D and London SN (1996) Numerical and structural chromosome aberrations induced by etoposide (VP16) during oocyte maturation of mice: Transmission to one-cell zygotes and damage to dictyate oocytes. Mutagenesis 11,357-361.
29. Marchetti F and Wyrobek AJ (2005) Mechanisms and consequences of paternally-transmitted chromosomal abnormalities. Birth Defects Res C Embryo Today 75,112-129.
30. Marchetti F, Bishop JB, Lowe X, Generoso WM, Hozier J and Wyrobek AJ (2001) Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse. PNAS 98,3952-3957.
31. Martin RH, Spriggs E, Ko E and Rademaker AW (1995) The relationship between paternal age, sex ratios, and aneuploidy frequencies in human sperm, as assessed by multicolor FISH. Am J Hum Genet 57,1395-1399.
32. Martin RH, Ernst S, Rademaker A, Barclay L, Ko E and Summers N (1997) Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy. Hum Genet 99,214-8.
33. Martin R, Ernst S, Rademaker A, Barclay L, Ko E and Summers N (1999) Analysis of sperm chromosome complements before, during, and after chemotherapy. Cancer Genet Cytogenet 108,133-136.
34. Moens PB (1990) Unravelling meiotic chromosomes: Topoisomerase II and other proteins. J Cell Sci 97,1-3.
35. Oakberg EF (1956) Duration of spermatogenesis in the mouse and timing of stages of the cycle of the seminiferous epithelium. Am J Anat 99,507-516.
36. Pectasides D, Pectasides M, Farmakis D, Nikolaou M, Koumpou M, Kostopoulou V and Mylonakis N (2004) Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC90) combination therapy. Eur Urol 45,187-193.
37. Poljak L and Kas E (1995) Resolving the role of topoisomerase II in chromatin structure and function. Trends Cell Biol 5,348-354.
38. Robbins WA, Meistrich ML, Moore D, Hagemeister FB, Weier HU, Cassel MJ, Wilson G, Eskenazi B and Wyrobek AJ (1997) Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nature Genet 16,74-78.
39. Rose D, Thomas W and Holm C (1990a) Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II. Cell 60,1009-1017.
40. Rose MD, Winston F and Hieter P (1990b) Methods in yeast genetics: A laboratory course manual. Cold Spring Harbour, NY, Cold Spring Harbour Laboratory Press.
41. Rubes J, Lowe X, Moore DI, Perreault S, Slott V, Everson D, Selevan S and Wyrobek AJ (1998) Smoking cigarettes is associated with increased sperm disomy in teenage men. Fertil Steril 70,715-723.
42. Russell LB, Hunsicker PR, Johnson DK and Shelby MD (1998) Unlike other chemicals, etoposide (a topoisomerase-II inhibitor) produces peak mutagenicity in primary spermatocytes of the mouse. Mutat Res 400,279-286.
43. Shelby MD (1996) Selecting chemicals and assays for assessing mammalian germ cell mutagenicity. Mutat Res 325,159-167.
44. Sloter E, Lowe X, Moore DI, Nath J and Wyrobek AJ (2000) Multicolour FISH analysis of chromosomal breaks, duplications, deletions, and numerical abnormalities in the sperm of healthy men. Am J Hum Genet 67,862-872.
45. Smith PJ (1990) DNA topoisomerase dysfunction: A new goal for antitumour chemotherapy. BioEssays 12,167-172.
46. Snedecor GW and Cochran WG (1967) Statistical methods. Ames, IA, Iowa State University Press.
47. Suzuki H, Ikeda T, Yamgishi T, Nakaike S, Nakane S and Ohsawa M (1995) Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells. Mutat Res 328,151-161.
48. Suzuki H, Tarumoto Y and Ohsawa M (1997) Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations. Mutagenesis 12,29-33.
49. Tateno H and Kamiguchi Y (2001) Meiotic stage-dependent induction of chromosome aberrations in Chinese hamster primary oocytes exposed to topoisomerase II inhibitor etoposide. Mutat Res 476,139-148.
50. Van Hummelen P, Lowe XR and Wyrobek AJ (1996) Simultaneous detection of structural and numerical chromosome abnormalities in sperm of healthy men by multicolor fluorescence in situ hybridization. Hum Genenet 98,608-615.
51. Van Hummelen P, Manchester D, Lowe X and Wyrobek AJ (1997) Meiotic segregation, recombination, and gamete aneuploidy assessed in a t(1;10) (p22.1;q22.3) reciprocal translocation carrier by three- and four probe multicolor FISH in sperm. Am J Hum Genet 61,651-659.
52. Wang JC, Caron PR and Kim RA (1990) The role of DNA topoisomerases in recombination and genome stability: A double-edged sword? Cell 62,403-406.
53. Witt KL and Bishop JB (1996) Mutagenicity of anticancer drugs in mammalian germ cells. Mutat Res 355,209-234.
54. Wyrobek AJ, Schmid TE and Marchetti F (2005a) Relative susceptibilities of germ cells to genetic defects induced by cancer chemotherapies. J Natl Cancer Inst Monogr 34,31-35.
55. Wyrobek AJ, Schmid TS and Marchetti F (2005b) Cross-species sperm-FISH assays for chemical testing and assessing paternal risk for chromosomally abnormal pregnancies. Environ Mol Mutagen 45,271-283.